US 8957070
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
granted A61PA61P3/04A61P3/10
Quick answer
US patent 8957070 (Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity) held by Takeda Pharmaceutical Company Limited expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61P, A61P3/04, A61P3/10, A61P43/00